Evidence map›Paper›PMID 41532149›Full record

ArticleNeuropsychiatric disease and treatment2026

Identifying Physiological and Cognitive Indicators of Subthreshold Depression and Major Depressive Disorder Progression Risk.

Ayaka Shimizu, Satoshi Yokoyama, Alan S R Fermin, Yuki Mitsuyama, Keisuke Mizoi, Junichiro Yoshimoto, Toshi A Furukawa, Koki Takagaki, Yuri Okamoto, Yasumasa Okamoto and 1 more

Abstract read
In one paragraph

Article in Neuropsychiatric disease and treatment, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ayaka ShimizuDepartment of Psychiatry and Neurosciences, Hiroshima University, Hiroshima, Japan.ORCID 0009-0008-6590-316X
Satoshi YokoyamaFaculty of Humanities, Niigata University, Niigata, Japan.
Alan S R FerminDepartment of Psychiatry and Neurosciences, Hiroshima University, Hiroshima, Japan.
Yuki MitsuyamaDepartment of Psychiatry and Neurosciences, Hiroshima University, Hiroshima, Japan.
Keisuke MizoiDepartment of Psychiatry and Neurosciences, Hiroshima University, Hiroshima, Japan.
Junichiro YoshimotoDepartment of Biomedical Data Science, School of Medicine, Fujita Health University, Aichi, Japan.ORCID 0000-0001-7995-0321
Toshi A FurukawaOffice of Institutional Advancement and Communications, Kyoto University, Kyoto, Japan.
Koki TakagakiHealth Service Center, Hiroshima University, Hiroshima, Japan.
Yuri OkamotoHealth Service Center, Hiroshima University, Hiroshima, Japan.
Yasumasa OkamotoDepartment of Psychiatry and Neurosciences, Hiroshima University, Hiroshima, Japan.
Go OkadaDepartment of Psychiatry and Neurosciences, Hiroshima University, Hiroshima, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Subthreshold depression (StD), depressive symptoms below the diagnostic threshold for major depressive disorder (MDD), is associated with functional impairment and increased risk of MDD onset, but its physiological and cognitive characteristics remain unclear. This study aimed to identify objective markers of StD and validate predictive factors for MDD onset. Patients and Methods: Among 168 university students, participants were classified into a StD group (n=87) and a healthy control group (n=81) using the Beck Depression Inventory-II (BDI-II). The StD group was further subdivided into "low depression" (BDI-II < 10, n = 21) and "maintained depression" (BDI-II ≥ 10, n = 66) based on their BDI-II scores at baseline. Assessments included voice characteristics, heart rate variability (HRV), peripheral body temperature, emotion recognition, and neurocognitive tasks. Between-group differences were tested using ANOVA and MANOVA, and participants were followed for MDD onset at 3-month intervals until March 2024. Results: Compared to controls, the StD group showed increased vocal arousal (p = 0.007), elevated peripheral body temperature (p < 0.001), and reduced low-frequency HRV (p = 0.018). Sustained attention and executive function were impaired (p < 0.05). Accuracy in emotion recognition was lower for happy and surprised expressions (p = 0.030; p = 0.038). Subgroup analysis revealed more pronounced impairments in HRV, executive function, and emotion recognition in the maintained depression subgroup, which also had a higher MDD incidence (7 cases). In contrast, the low depression group showed selective attentional deficits and impaired emotion recognition, but no MDD onset. Conclusion: StD correlates with physiological and cognitive abnormalities reflecting MDD, and persistent symptoms suggest increased progression risk. These findings present candidate markers (voice arousal, HRV, body temperature, emotion recognition) for early identification and risk stratification; however, conclusions should be interpreted cautiously given the exploratory design.

Indexed as

cognitive functionemotion recognitionheart rate variabilitymajor depressive disordersubthreshold depressionvoice analysis

Identifiers

PMID41532149
PMCPMC12998667

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.